FDA recall Z-3108-2017

CryoLife, Inc. · Class II · device

Product

On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic position in cases that involve an ascending aortic aneurysm or other associated aortic disease.

Reason for recall

Mix-up RGA (Return Goods Authorization) leading to 5 devices being redistributed and implanted 2 patients.

Distribution

US Distribution to the state of : Illinois

Key facts

Status
Terminated
Initiation date
2014-02-12
Report date
2017-09-13
Termination date
2019-11-05
Voluntary/Mandated
Voluntary: Firm initiated
Location
Kennesaw, GA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-3108-2017